Literature DB >> 15223611

Effect of influenza vaccinations on immune response and serum eotaxin level in patients with allergic bronchial asthma.

Karina Jahnz-Rózyk1, Lidia B Brydak, Tomasz Targowski, Magdalena Machała, Tadeusz Plusa.   

Abstract

BACKGROUND: One of the most promising markers of allergic inflammation is eotaxin, which has a selective influence on the migration of eosinophils. Its serum content significantly correlates with the intensity of allergic symptoms, so it might be interesting to know whether vaccination has any influence on serum expression of this chemokine. AIMS: Comparison of the humoral response to influenza vaccine and post-vaccination changes in the serum eotaxin level in patients with allergic bronchial asthma and healthy controls.
METHODS: Forty-two asthmatics and 45 healthy individuals were vaccinated with a single dose of influenza subunit vaccine (Influvac). The serum eotaxin level and the antibody response to haemagglutinin (HI) and neuraminidase (NI) glycoproteins were measured before and after vaccination.
RESULTS: A significant increase of geometric mean titres of HI and NI was observed in both groups. There were no significant differences between the groups in meanfold increase of HI and NI titres, response rate and protective level of HI. After vaccination, a significant decrease of the mean serum eotaxin value was observed in patients with asthma (149.4 +/- 71.0 versus 125.1 +/- 67.0, p= 0.0017), while no similar effect was present in healthy individuals (153.4 +/- 56.9 versus 159.3 +/- 54.4, p= 0.5).
CONCLUSIONS: The results indicate that in patients with allergic bronchial asthma influenza vaccinations assure efficient protective antibody level and modulate the serum level of eotaxin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223611      PMCID: PMC1781554          DOI: 10.1080/09511920410001713501

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  28 in total

1.  Development of a sensitive enzyme-linked immunosorbent assay for eotaxin and measurement of its levels in human blood.

Authors:  A Morita; K Shimosako; S Kikuoka; Y Taniguchi; M Kitaura; K Sasakura; M Tamaki; T Tsuji; H Teraoka; O Yoshie; T Nakajima; K Hirai
Journal:  J Immunol Methods       Date:  1999-06-24       Impact factor: 2.303

2.  Influenza vaccination in asthma.

Authors:  W U Hassan; A F Henderson; N P Keaney
Journal:  Lancet       Date:  1992-01-18       Impact factor: 79.321

3.  Observations on excess mortality associated with epidemic influenza.

Authors:  T C EICKHOFF; I L SHERMAN; R E SERFLING
Journal:  JAMA       Date:  1961-06-03       Impact factor: 56.272

4.  Serum cytokine levels and antibody response to influenza vaccine in the elderly.

Authors:  T Krakauer; C Russo
Journal:  Immunopharmacol Immunotoxicol       Date:  2001-02       Impact factor: 2.730

5.  Socioeconomics of influenza and influenza vaccination in Europe.

Authors:  K G Nicholson
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

6.  Safety and immunogenicity of a purified haemagglutinin antigen in very young high-risk children.

Authors:  J R Groothuis; M V Lehr; M J Levin
Journal:  Vaccine       Date:  1994-02       Impact factor: 3.641

7.  Association between rise in antibodies and increase in airway sensitivity after intramuscular injection of killed influenza virus in asthmatic patients.

Authors:  J Banks; C Bevan; A Fennerty; P Ebden; E H Walters; A P Smith
Journal:  Eur J Respir Dis       Date:  1985-04

8.  Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals.

Authors:  R A Taha; E M Minshall; D Miotto; A Shimbara; A Luster; J C Hogg; Q A Hamid
Journal:  J Allergy Clin Immunol       Date:  1999-03       Impact factor: 10.793

9.  Influenza virus vaccination of patients with chronic lung disease.

Authors:  G J Gorse; E E Otto; C C Daughaday; F K Newman; C S Eickhoff; D C Powers; R H Lusk
Journal:  Chest       Date:  1997-11-05       Impact factor: 9.410

10.  Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients.

Authors:  E A Wierenga; M Snoek; C de Groot; I Chrétien; J D Bos; H M Jansen; M L Kapsenberg
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

View more
  3 in total

Review 1.  An Overlook to the Characteristics and Roles Played by Eotaxin Network in the Pathophysiology of Food Allergies: Allergic Asthma and Atopic Dermatitis.

Authors:  Zahra Ahmadi; Gholamhossein Hassanshahi; Hossein Khorramdelazad; Nahid Zainodini; Leila Koochakzadeh
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

2.  Hepatitis B vaccination in women healthcare workers: a seroepidemiological survey.

Authors:  C Locquet; J-L Marande; D Choudat; G Vidal-Trecan
Journal:  Eur J Epidemiol       Date:  2007-02-13       Impact factor: 8.082

Review 3.  Influenza diagnosis and vaccination in Poland.

Authors:  L B Brydak; A Wozniak-Kosek; A Nitsch-Osuch
Journal:  Respir Physiol Neurobiol       Date:  2013-02-16       Impact factor: 1.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.